Genelux Corporation (GNLX)
NASDAQ: GNLX · IEX Real-Time Price · USD
2.210
-0.090 (-3.91%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Genelux Revenue
Genelux had revenue of $8.00K in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $8.00K. In the year 2023, Genelux had annual revenue of $170.00K.
Revenue (ttm)
$8.00K
Revenue Growth
-99.93%
P/S Ratio
9,489.73
Revenue / Employee
$348
Employees
23
Market Cap
75.92M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 170.00K | -10.90M | -98.46% |
Dec 31, 2022 | 11.07M | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGNLX News
- 2 months ago - Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants - GlobeNewsWire
- 2 months ago - Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants - GlobeNewsWire
- 2 months ago - Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates - GlobeNewsWire
- 4 months ago - Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 8 months ago - Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer - GlobeNewsWire
- 8 months ago - Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates - GlobeNewsWire
- 11 months ago - Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 11 months ago - Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference - GlobeNewsWire